Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Similar documents
Eicher Motors. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Bharat Petroleum Corporation

Asian Paints. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Britannia Industries

Coal India. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Jindal Steel & Power

Hindustan Zinc. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Jindal Steel & Power

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Larsen & Toubro. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Indraprastha Gas. Source: Company Data; PL Research

Tata Steel. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

HDFC Standard Life Insurance

ICICI Prudential Life Insurance

LIC Housing Finance. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Britannia Industries

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

FY20E FY21E FY20E FY21E

Maruti Suzuki (MSIL IN)

Aurobindo Pharma. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Cadila Healthcare. Source: Company Data; PL Research

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Apollo Tyres. Profitability likely to improve. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

TVS Motors (TVSL IN)

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Glenmark Pharmaceuticals

Gujarat State Fertilisers & Chemicals

Pantaloon Retail India

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Mindtree. Source: Company Data; PL Research.

Dr. Reddy's Laboratories

Punjab National Bank

Cadila Healthcare. Source: Company Data; PL Research

Larsen & Toubro (LT IN)

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Dr. Reddy's Laboratories

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Glenmark Pharmaceuticals

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Transcription:

Continues to ride high! Accumulate November 14, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs30,083 Target Price Rs33,465 Implied Upside 11.2% Sensex 32,942 Nifty 10,187 (Prices as on November 14, 2017) Trading data Market Cap. (Rs bn) 817.1 Shares o/s (m) 27.2 3M Avg. Daily value (Rs m) 1125.5 Major shareholders Promoters 50.58% Foreign 32.09% Domestic Inst. 4.49% Public & Other 12.84% Stock Performance (%) 1M 6M 12M Absolute (4.1) 3.1 38.3 Relative (5.7) (6.0) 15.5 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2019 943.9 1,022.6 (7.7) 2020 1,118.6 1,216.5 (8.1) Price Performance (RIC: EICH.BO, BB: EIM IN) (Rs) 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 Nov 16 Jan 17 Source: Bloomberg Mar 17 May 17 Jul 17 Sep 17 Nov 17 (EIM) Q2FY18 performance marginally missed our estimates, wherein revenue growth was at 23.5% YoY to Rs21.7bn (PLe: Rs22.1bn), and the EBITDA margin came in at 31.5% (PLe: 31.9%). With higher share of profit from its joint venture, consolidated net profit for the company grew ~25% YoY to Rs5.18bn (marginally below PLe). Eicher s standalone performance was decent with net profit growth of ~23% YoY to Rs4.9bn. Demand for RE remains healthy, with a 1.5 2 month waiting period for the Classic 350. Expansion of network by RE will help ramp up capacity utilisation on the upcoming facility in the current fiscal. New 650cc models, Interceptor 650cc and Continental GT 650, to be launched in Apr 18 should help boost exports for the company in FY19. While H1FY18 was somewhat weak for Volvo Eicher Commercial Vehicles (VECV), it had outperformed the CV industry in FY17 and improved CV demand is expected to provide additional positives for VECV in CY18, rendering overall long term outlook for EIM favourable. We maintain Accumulate, with a target price of Rs33,465 (previously Rs32,342). At current market price, the stock trades at 38x FY18E and 32x FY19E cons EPS. Standalone performance: Volume growth was healthy at 21.5% YoY to ~202.9K units, up 10.3% QoQ (highest quarterly volumes for Royal Enfield). Total income grew 22.9% YoY to Rs21.6bn, with realisations inching up 1% YoY and a 4% YoY decline in other operating income (PLe: Rs22.2bn). EBITDA margin came in at 31.9%, up 60bps YoY and 50bps QoQ (PLe: 32%). Gross margins dipped 10bps YoY (up 90bps QoQ), staff costs as a % of sales were higher 60bps YoY while other expenses as a % of sales were lower 130bps YoY. EBITDA grew ~25% YoY to Rs6.9bn (PLe: Rs7.1bn). Despite depreciation provision being higher YoY, net profit for the quarter stood at Rs4.9bn, up 22.8% YoY (PLe: Rs5.2bn). Contd...2 Key financials (Y/e March) 2017 2018E 2019E 2020E Revenues (Rs m) 70,334 86,427 102,274 120,030 Growth (%) 0.9 22.9 18.3 17.4 EBITDA (Rs m) 21,740 26,812 32,297 38,253 PAT (Rs m) 16,671 21,345 25,636 30,382 EPS (Rs) 613.8 785.9 943.9 1,118.6 Growth (%) (21.9) 28.0 20.1 18.5 Net DPS (Rs) 100.0 120.1 144.1 172.9 Profitability & Valuation 2017 2018E 2019E 2020E EBITDA margin (%) 30.9 31.0 31.6 31.9 RoE (%) 37.1 34.9 32.9 31.1 RoCE (%) 36.8 34.7 32.7 31.0 EV / sales (x) 11.6 9.4 7.9 6.7 EV / EBITDA (x) 37.6 30.4 25.1 21.0 PE (x) 49.0 38.3 31.9 26.9 P / BV (x) 15.3 11.9 9.4 7.5 Net dividend yield (%) 0.3 0.4 0.5 0.6 Source: Company Data; PL Research Q2FY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Consolidated performance: Consolidated income grew 23.5% YoY to Rs21.7bn (PLe: Rs22.2bn) in Q2FY18. EBITDA growth was 26% YoY to Rs6.8bn (PLe: Rs7.1bn), with operating margins at 31.5% (PLe: 31.9%). Owing to lower than expected non operating income, higher depreciation provision and higher tax rate, PAT for the quarter came in at Rs4.8bn (PLe: Rs5.1bn). However, higher share of profit from VECV for Q2FY18 at Rs403m (against Rs252mn in Q2FY17 and Rs250mn in Q1FY18) lead to consolidated net profit to grow 25.4% YoY to Rs5.18bn (marginally below PLe). Conference Call highlights: Oder booking for RE remains strong. For the Classic 350, the waiting period is still in the range of 1.5 2 months. VECV market share declined to 13% in Q2FY18 from 13.6% in Q2FY17. The company had taken an average 1% price hike for VECVs in Sep 17 despite heavy discounting in the industry. For Royal Enfield, the Company has reiterated its production target of ~825K units in the current fiscal. With the ongoing capacity ramp up, realisable capacity is expected to reach ~900K units by FY19. RE s new 650cc motorcycles Interceptor 650 and Continental GT 650 are expected to be commercially launched by April 18 in the international markets. The management expects these models to become the highest selling RE models in international markets. RE started production at the third plant in Aug 17. Currently, less than 10% of monthly sales are produced at this plant while it is expected to be ramped up to ~25K units per month by Q1FY19. The company is consistently expanding its network for Royal Enfield. Currently, RE has ~7,500 touchpoints in India. Also, the company has ~30 exclusive RE dealers in the international markets. November 14, 2017 2

Exhibit 1: Q2FY18 Result Overview Consolidated (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Net Revenues 21,673 17,549 23.5 20,006 41,679 33,105 25.9 Raw Materials 11,285 9,116 23.8 10,573 21,858 17,429 25.4 % of Net Sales 52.1 51.9 52.8 52.4 52.6 Personnel 1,355 1,000 35.5 1,206 2,561 1,906 34.4 % of Net Sales 6.3 5.7 6.0 6.1 5.8 Manufacturing & Other Exp 2,208 2,011 9.8 2,021 4,229 3,647 15.9 % of Net Sales 10.2 11.5 10.1 10.1 11.0 Total Expenditure 14,848 12,127 22.4 13,799 28,647 22,982 24.7 EBITDA 6,825 5,422 25.9 6,207 13,032 10,124 28.7 EBITDA Margin (%) 31.5 30.9 31.0 31.3 30.6 Depreciation 492 359 37.2 452 944 753 25.4 EBIT 6,334 5,063 25.1 5,755 12,089 9,371 29.0 Interest Expenses 13 8 57.3 11 24 15 59.6 Non operating income 699 665 5.2 777 1,477 1,133 30.4 PBT 7,020 5,720 22.7 6,521 13,541 10,489 29.1 Tax Total 2,243 1,840 21.9 2,175 4,418 3,314 33.3 Tax Rate (%) Total 32.0 32.2 33.4 32.6 31.6 Reported PAT 4,777 3,879 23.1 4,346 9,123 7,175 27.1 Share of Profit 403 252 250 654 719 Profit after MI 5,180 4,132 25.4 4,596 9,776 7,895 23.8 Adj. PAT 5,180 4,132 25.4 4,596 9,776 7,895 23.8 Source: Company Data, PL Research November 14, 2017 3

Exhibit 2: Q1FY18 Result Overview Standalone (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Net Revenues 21,636 17,625 22.8 19,999 41,635 33,200 25.4 Raw Materials 11,270 9,161 23.0 10,591 21,861 17,467 25.2 % of Net Sales 52.1 52.0 53.0 52.5 52.6 Personnel 1,302 956 36.1 1,160 2,462 1,822 35.2 % of Net Sales 6.0 5.4 5.8 5.9 5.5 Manufacturing & Other Exp 2,164 1,984 9.1 1,971 4,135 3,589 15.2 % of Net Sales 10.0 11.3 9.9 9.9 10.8 Total Expenditure 14,736 12,101 21.8 13,722 28,457 22,878 24.4 EBITDA 6,901 5,524 24.9 6,278 13,178 10,322 27.7 EBITDA Margin (%) 31.9 31.3 31.4 31.7 31.1 Depreciation 490 358 36.9 450 940 751 25.1 EBIT 6,411 5,166 24.1 5,827 12,238 9,571 27.9 Interest Expenses 7 8 4.0 7 14 14 1.4 Non operating income 699 665 5.2 1,294 1,994 1,133 76.0 PBT 7,103 5,823 22.0 7,115 14,218 10,690 33.0 Tax Total 2,239 1,862 20.2 2,172 4,410 3,357 31.4 Tax Rate (%) Total 31.5 32.0 30.5 31.0 31.4 Reported PAT 4,864 3,962 22.8 4,943 9,808 7,333 33.8 Adj. PAT 4,864 3,962 22.8 4,943 9,808 7,333 33.8 Source: Company Data, PL Research Note: FY16 is for 15 months Exhibit 3: Operating Metrics Standalone (Rs m) Y/e March Q2FY18 Q2FY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Sales Volume (nos) 202,867 166,941 21.5 183,998 386,865 314,424 23.0 Net Realisation/Vehicle 106,651 105,576 1.0 108,691 107,622 105,589 1.9 Material cost / vehicle 55,553 54,874 1.2 57,559 56,507 55,554 1.7 Gross Profit / vehicle 51,098 50,701 0.8 51,132 51,114 50,035 2.2 Employee cost /vehicle 6,418 5,729 12.0 6,303 6,363 5,793 9.8 Other expenses / vehicle 10,665 11,883 (10.3) 10,712 10,687 11,414 (6.4) EBITDA/vehicle 34,015 33,089 2.8 34,117 34,064 32,828 3.8 Net Profit/vehicle 23,978 23,731 1.0 26,866 25,352 23,321 8.7 Source: Company Data, PL Research November 14, 2017 4

Income Statement (Rs m) Net Revenue 70,334 86,427 102,274 120,030 Raw Material Expenses 37,045 46,022 55,200 64,826 Gross Profit 33,289 40,405 47,075 55,204 Employee Cost 4,024 4,813 5,525 6,344 Other Expenses 7,526 8,780 9,253 10,608 EBITDA 21,740 26,812 32,297 38,253 Depr. & Amortization 1,538 1,921 2,401 3,001 Net Interest 36 33 33 33 Other Income 2,273 3,182 3,501 3,851 Profit before Tax 22,439 28,040 33,363 39,070 Total Tax 7,203 8,847 10,525 12,324 Profit after Tax 15,236 19,193 22,838 26,745 Ex Od items / Min. Int. 1,435 2,152 2,798 3,637 Adj. PAT 16,671 21,345 25,636 30,382 Avg. Shares O/S (m) 27.2 27.2 27.2 27.2 EPS (Rs.) 613.8 785.9 943.9 1,118.6 Cash Flow Abstract (Rs m) C/F from Operations 23,896 22,057 26,166 30,795 C/F from Investing (21,152) (17,262) (16,000) (16,000) C/F from Financing (2,985) (3,835) (4,595) (5,508) Inc. / Dec. in Cash (241) 960 5,570 9,287 Opening Cash 492 251 1,210 6,781 Closing Cash 251 1,210 6,781 16,068 FCFF 17,625 14,176 23,930 29,398 FCFE 17,843 14,176 23,930 29,398 Key Financial Metrics Growth Revenue (%) 0.9 22.9 18.3 17.4 EBITDA (%) (12.6) 23.3 20.5 18.4 PAT (%) (21.9) 28.0 20.1 18.5 EPS (%) (21.9) 28.0 20.1 18.5 Profitability EBITDA Margin (%) 30.9 31.0 31.6 31.9 PAT Margin (%) 23.7 24.7 25.1 25.3 RoCE (%) 36.8 34.7 32.7 31.0 RoE (%) 37.1 34.9 32.9 31.1 Balance Sheet Net Debt : Equity (0.1) (0.1) Net Wrkng Cap. (days) (46) (46) (45) (45) Valuation PER (x) 49.0 38.3 31.9 26.9 P / B (x) 15.3 11.9 9.4 7.5 EV / EBITDA (x) 37.6 30.4 25.1 21.0 EV / Sales (x) 11.6 9.4 7.9 6.7 Earnings Quality Eff. Tax Rate 32.1 31.6 31.5 31.5 Other Inc / PBT 10.1 11.3 10.5 9.9 Eff. Depr. Rate (%) 7.7 6.4 6.9 7.5 FCFE / PAT 107.0 66.4 93.3 96.8 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Shareholder's Funds 53,450 68,842 87,118 108,389 Total Debt 444 444 444 444 Other Liabilities 778 778 778 778 Total Liabilities 54,672 70,063 88,339 109,611 Net Fixed Assets 12,466 16,807 19,406 21,405 Goodwill Investments 49,871 60,871 71,871 82,871 Net Current Assets (7,665) (7,614) (2,937) 5,335 Cash & Equivalents 251 1,210 6,781 16,068 Other Current Assets 7,319 8,604 9,875 11,251 Current Liabilities 15,235 17,429 19,593 21,984 Other Assets Total Assets 54,672 70,063 88,339 109,611 Quarterly Financials (Rs m) Y/e March Q3FY17 Q4FY17 Q1FY18 Q2FY18 Net Revenue 18,348 18,881 20,006 21,673 EBITDA 5,770 5,848 6,207 6,825 % of revenue 31.4 31.0 31.0 31.5 Depr. & Amortization 356 432 452 492 Net Interest 10 11 11 13 Other Income 590 551 777 699 Profit before Tax 5,995 5,956 6,521 7,020 Total Tax 2,000 1,890 2,175 2,243 Profit after Tax 4,182 4,594 4,596 5,180 Adj. PAT 4,182 4,594 4,596 5,180 Key Operating Metrics Royal Enfield volumes (units) 666,490 814,451 936,618 1,072,428 Passenger M&HCV Sales (units) 6,883 7,743 8,711 9,800 Goods M&HCV Sales (units) 33,642 37,847 43,524 50,053 Passenger LCV sales (units) 6,645 7,310 8,406 9,667 Goods LCV sales (units) 9,961 11,206 12,607 14,183 Total CV sales (units) 57,131 64,106 73,248 83,703 Total volumes (units) 723,621 878,557 1,009,867 1,156,131 Standalone realisation per vehicle (Rs) 105,142 105,792 108,875 111,607 Standalone gross margin per vehicle (Rs) 49,984 49,637 50,287 51,503 Standalone EBITDA per vehicle (Rs) 33,096 33,343 34,887 36,060 Standalone EBITDA margin (%) 31 31 32 32 Standalone profit per vehicle (Rs) 23,407 23,881 24,685 25,230 Consolidated realisation per vehicle (Rs) 96,777 97,985 100,895 111,520 Consolidated gross margin per vehicle (Rs) 46,003 45,990 46,615 51,476 Consolidated EBITDA per vehicle (Rs) 30,043 30,518 31,981 35,671 Consolidated profit per vehicle (Rs) 23,038 24,296 25,385 28,331 Source: Company Data, PL Research. November 14, 2017 5

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 44.5% 39.1% 16.4% 0.0% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Rohan Korde (MMS, BCom), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Rohan Korde (MMS, BCom), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. November 14, 2017 6